✦ LIBER ✦

Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck

✍ Scribed by Kim, J G; Sohn, S K; Kim, D H; Baek, J H; Jeon, S B; Chae, Y S; Lee, K B; Park, J S; Sohn, J H; Kim, J C

Book ID: 109998658
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 98 KB
Volume: 93
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6602849

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I trial of concurrent chemoradioth

Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)

✍ Katori, H; Tsukuda, M; Mochimatu, I; Ishitoya, J; Kawai, S; Mikami, Y; Matsuda, 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 97 KB

Randomized controlled phase II compariso

Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neck

✍ Mamoru Tsukuda; Junichi Ishitoya; Hideki Matsuda; Choichi Horiuchi; Takahide Tag 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 249 KB

Phase II trial of cisplatin and capecita

Phase II trial of cisplatin and capecitabine in patients with squamous cell carcinoma of the head and neck, and correlative study of angiogenic factors

✍ Hitt, R; Jimeno, A; Rodríguez-Pinilla, M; Rodríguez-Peralto, J L; Millán, J M; L 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 114 KB

Weekly 5-fluorouracil plus cisplatin for

Weekly 5-fluorouracil plus cisplatin for concurrent chemoradiotherapy in patients with locally advanced head and neck cancer

✍ Young Joo Lee; Chang Geol Lee; Byoung Chul Cho; Gwi Eon Kim; Hye Jin Choi; Eun C 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB

## Abstract ## Background. In locally advanced head and neck cancer, concurrent chemoradiotherapy (CRT) with combined 5‐fluorouracil (5‐FU) and cisplatin has increased acute toxicities as well as survival. Once‐weekly chemotherapeutic administration schedule may reduce severe toxicities. Thus, we

Single-arm phase II study of multiagent

Single-arm phase II study of multiagent concurrent chemoradiotherapy and gefitinib in locoregionally advanced squamous cell carcinoma of the head and neck

✍ Cristina P. Rodriguez; David J. Adelstein; Lisa A. Rybicki; Jerrold P. Saxton; R 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 380 KB

Phase I trial of chemoradiotherapy with

Phase I trial of chemoradiotherapy with the combination of S-1 plus cisplatin for patients with unresectable locally advanced squamous cell carcinoma of the head and neck

✍ Makoto Tahara; Hironobu Minami; Mitsuhiko Kawashima; Kenji Kawada; Hirofumi Muka 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB